During the past decade, NARI Pune CRS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NARI Pune CRS" #1 sponsor was "AIDS Clinical Trials Group" with 6 trials, followed by "Becton, Dickinson and Company" with 1 trials sponsored, "Emory University" with 1 trials sponsored, "HIV Prevention Trials Network" with 1 trials sponsored and "International AIDS Vaccine Initiative" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NARI Pune CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials as a collaborator, "Children's Hospital of Philadelphia" with 1 trials as a collaborator, "HIV Prevention Trials Network" with 1 trials as a collaborator, "Microbicide Trials Network" with 1 trials as a collaborator and "National AIDS Research Institute, India" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "NARI Pune CRS" are "HIV Infections" (4 trials), "HIV-1 Infection" (3 trials), "HIV Infection" (2 trials), "Tuberculosis" (2 trials) and "Acquired Immunodeficiency Syndrome" (1 trials). Many other conditions were trialed in "NARI Pune CRS" in a lesser frequency.

Most popular intervention types in "NARI Pune CRS" are "Drug" (5 trials), "Other" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atazanavir" (2 trials), "Efavirenz" (2 trials), "Emtricitabine/Tenofovir disoproxil fumarate" (2 trials), "Lamivudine" (2 trials) and "Abacavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "NARI Pune CRS" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "NARI Pune CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in NARI Pune CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NARI Pune CRS, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".